Rockwell Medical Past Earnings Performance

Past criteria checks 0/6

Rockwell Medical has been growing earnings at an average annual rate of 29.4%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 9.5% per year.

Key information

29.4%

Earnings growth rate

46.0%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.5%
Return on equity-4.2%
Net Margin-1.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Rockwell Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:RWMA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2499-1160
30 Jun 2494-5151
31 Mar 2487-9151
31 Dec 2384-9141
30 Sep 2381-9151
30 Jun 2376-12161
31 Mar 2376-13172
31 Dec 2273-19183
30 Sep 2269-25184
30 Jun 2266-29205
31 Mar 2263-32207
31 Dec 2162-33217
30 Sep 2162-32237
30 Jun 2161-32238
31 Mar 2162-31227
31 Dec 2062-31247
30 Sep 2063-30247
30 Jun 2063-30257
31 Mar 2062-33288
31 Dec 1961-34307
30 Sep 1963-36317
30 Jun 1964-33316
31 Mar 1964-35294
31 Dec 1863-32236
30 Sep 1861-32216
30 Jun 1859-32207
31 Mar 1858-27217
31 Dec 1757-26236
30 Sep 1756-22235
30 Jun 1754-21245
31 Mar 1754-20226
31 Dec 1653-20216
30 Sep 1654-21217
30 Jun 1656-18207
31 Mar 1655-16195
31 Dec 1555-14195
30 Sep 1556-15195
30 Jun 1555-17195
31 Mar 1555-17204
31 Dec 1454-21188
30 Sep 1454-231612
30 Jun 1453-331621
31 Mar 1453-411531

Quality Earnings: RWMA is currently unprofitable.

Growing Profit Margin: RWMA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RWMA is unprofitable, but has reduced losses over the past 5 years at a rate of 29.4% per year.

Accelerating Growth: Unable to compare RWMA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RWMA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: RWMA has a negative Return on Equity (-4.24%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 12:32
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rockwell Medical, Inc. is covered by 16 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
Jonathan AschoffBrean Capital
Ritu BaralCanaccord Genuity